Lv21
196 积分 2024-01-08 加入
Rifaximin and alternative agents in the management of irritable bowel syndrome: A comprehensive review
1个月前
已完结
Targeted antibiotic and dietary approaches in managing small intestinal bacterial overgrowth across irritable bowel syndrome subtypes
1个月前
已完结
Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth
1个月前
已完结
Intestinal pH: a major driver of human gut microbiota composition and metabolism
1个月前
已完结
Gastro-oesophageal reflux disease
1个月前
已完结
Gastroesophageal Reflux Disease
2个月前
已完结
Neutrophils: from IBD to the gut microbiota
2个月前
已完结
British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025
2个月前
已完结
Correction: British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025
2个月前
已关闭
The global burden of inflammatory bowel disease: from 2025 to 2045
2个月前
已完结
皖公网安备34019202002308
